SU-E-T-02: Radiobiological Comparison of Two Treatment Schemas in IMRT Prostate Radiotherapy

Medical Physics
T García HernándezJ Lopez Torrecilla

Abstract

Different fractionation schemas are used for the treatment of prostate with IMRT. Due to the low α/β of prostate hypofractionated schemas are achieving more importance. The purpose of this study is to compare two IMRT techniques from a radiobiological point of view in the treatment of high risk prostate cancer, the sequential IMRT technique (SIMRT) and a simultaneous integrated boost IMRT treatment (SIBIMRT). 20 patients were selected and planned using both treatment strategies to give an EQD2 of 82 Gy to prostate, 70 Gy to vesicles and 46 Gy to lymph nodes, using the linear quadratic model LQ supposing an α/β prostate=1.5 Gy. Dose volume histograms of prostate, rectum and bladder were calculated. Tumour Control Probabilities (TCP) and Normal Tissue Complication Probabilities (NTCP) were also calculated. As the prostate α/β is not known exactly the TCP has been calculated for different a/bprostate values ranging from 1.5 to 10 Gy. NTCPs of bladder and rectum were calculated also for α/β oar values ranging between 1 to 15 Gy. Both treatment strategies were found to be equivalent in terms of prostate ptv TCP and EQD2 for low α/β prostate=1.5 Gy. In the case of high α/β prostate values, 3 Gy and 10 Gy, EQD2 and TCP for prostate pt...Continue Reading

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.